Company news
Fulgent Genetics, Inc. news in 2022
Fulgent Genetics, Inc.'s news releases, calls and decks from 2022, newest first.
Fulgent Genetics to Participate in Piper Sandler’s 34th Annual Healthcare Conference
November 16, 2022
Fulgent Genetics Reports Third Quarter 2022 Financial Results
November 6, 2022
Fulgent Genetics Acquires Fulgent Pharma, Creating a New Paradigm in Precision Medicine for The Company
November 6, 2022
Fulgent Genetics to Participate in Credit Suisse’s 31st Annual Healthcare Conference
October 24, 2022
Fulgent Genetics to Announce Third Quarter 2022 Financial Results on Monday November 7, 2022
October 19, 2022
Fulgent Genetics Welcomes Dr. Michael Nohaile and Dr. Leonard Post to Board of Directors
August 3, 2022
Fulgent Genetics Reports Second Quarter 2022 Financial Results
August 3, 2022
Fulgent Genetics Announces Launch of PCR Based Test to Detect Monkeypox
August 3, 2022
Fulgent Genetics to Announce Second Quarter 2022 Financial Results on Thursday, August 4, 2022
July 18, 2022
Fulgent Genetics Reports First Quarter 2022 Financial Results
May 2, 2022
Fulgent Genetics Announces Promotions and Leadership Updates
May 2, 2022
Fulgent Genetics Announces Opening of New State-of-the-Art Oncology Laboratory in El Monte, California
May 2, 2022
Fulgent Genetics to Announce First Quarter 2022 Financial Results on Tuesday, May 3, 2022
April 17, 2022
Fulgent Genetics Agrees to Acquire Inform Diagnostics and Provides Preliminary First Quarter Revenue Results
April 17, 2022
Representatives of Fulgent Genetics to Participate in Oppenheimer’s 32nd Annual Healthcare Conference
March 7, 2022
Fulgent Genetics Announces $250 Million Share Repurchase Program
March 7, 2022
Helio Health Announces Publication of ENCORE Data in Hepatology Communications, Demonstrating Superior Performance of HelioLiver for Early Detection of Liver Cancer
March 6, 2022
EPIC SCIENCES AND FULGENT GENETICS COLLABORATE TO DELIVER DefineMBC™ RESULTS FOR METASTATIC BREAST CANCER PATIENTS
February 23, 2022
Fulgent Genetics Reports Fourth Quarter and Full Year 2021 Financial Results
February 22, 2022
Fulgent Genetics Announces Strategic Investment in Spatial Genomics
February 22, 2022
Fulgent Genetics to Announce Fourth Quarter and Full Year 2021 Financial Results on Wednesday February 23, 2022
February 13, 2022
Calls in 2022
Decks in 2022
- Investor Presentation (November 2022)
Investor deck · 28 slides · Nov 7, 2022
- Q3 2022 Earnings Presentation
Earnings · 20 slides · Nov 7, 2022
- Q2 2022 Earnings Presentation
Earnings · 28 slides · Aug 4, 2022
- Q1 2022 Earnings Presentation
Earnings · 28 slides · May 3, 2022
- Q4 2021 Earnings Presentation
Earnings · 29 slides · Feb 23, 2022